Steris Plc (STE) has been drawing considerable attention with multiple
Buy recommendations, impressive
earnings reports, forecasted revenue growth, and positive long-term outlooks. The company's stock has been undergoing a strong growth phase with an impressive jump seen in Q4 2025 EPS forecast, leading to an increase in the stock price.
KeyBanc has reiterated its 'Buy' rating, setting a price target at $288. The company's solid fundamentals have driven a robust growth in the stock market. Numerous
analysts anticipate further growth with Steris's strategic acquisitions to tackle macroeconomic issues and their propensity for meeting, even exceeding, earnings expectations. However, there have been concerns, as the stock price dipped 1.8% after the last earnings report. Notwithstanding this fluctuation, Steris announced its 20th consecutive year of dividend increases.
Jefferies initiated coverage with a 'Hold' rating, citing valuation concerns despite strategic acquisitions. Other notable events include Steris securing a $450M Navy contract, a CFO transition, and a strong recovery in its AST business. Regardless of the general optimism, the market showed only a marginal reaction to these developments.
Steris Plc STE News Analytics from Wed, 26 Mar 2014 07:00:00 GMT to Sat, 06 Sep 2025 02:51:05 GMT -
Rating 8
- Innovation 6
- Information 9
- Rumor 2
